Investigating how engineered microRNAs affect drug metabolism and processing
Recombinant microRNAs in xenobiotic metabolism and disposition
This study is looking at how tiny molecules called microRNAs affect how our bodies process medications, with the goal of finding better ways to develop and use drugs for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11056037 on NIH RePORTER |
What this research studies
This research focuses on understanding how noncoding microRNAs (miRNAs) regulate drug metabolism and disposition in the body. By developing a novel recombinant RNA technology, the study aims to produce natural miRNAs in a cost-effective manner, which could lead to better insights into how drugs are processed. The approach involves using bioengineered RNA agents to explore their role in pharmacotherapy, potentially improving drug development and treatment outcomes for patients. The research seeks to fill critical gaps in the current understanding of drug metabolism mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are undergoing pharmacotherapy and may experience variable drug responses.
Not a fit: Patients who are not currently on any medication or those with stable drug responses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective drug therapies tailored to individual metabolic responses.
How similar studies have performed: Previous research has shown promise in using recombinant proteins for drug development, suggesting potential success for this novel approach with miRNAs.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Yu, Aiming — University of California at Davis
- Study coordinator: Yu, Aiming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.